Sorry, this entry is only available in French.


PUBLISHED IN : Frontiers in Medicine and Frontiers in Surgery
free access international
Cet e-book édité par les membres du CRIOAc Lyon regroupe tous les articles publiés en accès libre dans le Research Topic de l’éditeur Frontiers intitulé “Innovative Approaches In The Management Of Bone and Joint Infection”. Pour le télécharger, cliquer ICI Bone and joint infections (BJI) are one of the most difficult-to-treat bacterial infectious diseases. Its management is complex, and requires
Editors: Umile Giuseppe Longo Nicolaas C. Budhiparama Sébastien Lustig Roland Becker João Espregueira-Mendes
This book provides an in-depth overview of the aetiology, treatment and prevention of infections following knee arthroplasty. It presents up-to-date information on available techniques and salvage procedures for complex patients with infected, total knee arthroplasty. Divided into 5 sections, this book explores biomaterials, clinical manifestations, diagnosis, treatment and prevention, including preoperative optimisation, in order to reduce knee infections. This book


sous la direction de Kühn Klaus-Dieter
free access international
Periprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved. For the patient concerned, it is necessary to promptly work out an adequate therapy solution to fight off the infection. Both the clinical experience of the surgeon and the


Groupe d’experts Infections ostéo-articulaires (IOA) de la Société Suisse d’Orthopédie et de Traumatologie et de la Société Suisse d’Infectiologie
Cet ouvrage est issu d’une collaboration entre la Société Suisse d’ Orthopédie et de Traumatologie et la Société Suisse d’ Infectiologie. Des spécialistes de ces deux sociétés ont élaboré les chapitres de ce livre dans le cadre du groupe d’experts Infections ostéo-articulaires. Cet ouvrage s’adresse aux orthopédistes et infectiologues qui ne sont pas quotidiennement confrontés à ces infections. Il présente


Abu Gafar Hossion, PhD (Editor) - The University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA
There have been news reports with the tales of many community acquired bacterial infections that lead to serious hospitalization. The last resort drug for these infections is vancomycin; an FDA approved glycopeptide antibiotic for the treatment of several bacterial infections, including infections caused by susceptible staphylococcus, streptococcus, enterococcus, and diphtheroid organisms. Around the world in 1997, initial reports of reduced vancomycin susceptibility